PharmAbcine, a clinical stage immune-oncology company, delivered a presentation at the Sachs 7th Annual Immuno-Oncology Innovation Forum, May 18th – May 20th, 2021.

This presentation video features Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, who introduced the core technology and pipeline assets such as Olinvacimab, PMC-309, and PMC-403 to discuss potential business development, licensing, and investment opportunities with global partners

Visit the link for the presentation video : https://bit.ly/3xTTwau